Wen-Wei Liang (@wenweiliang) 's Twitter Profile
Wen-Wei Liang

@wenweiliang

ID: 4442089697

calendar_today10-12-2015 22:42:53

36 Tweet

81 Takipçi

147 Takip Edilen

Nature Biotechnology (@naturebiotech) 's Twitter Profile Photo

A CRISPR screen targeting RNA identifies essential lncRNAs in human cells, revealing lncRNAs whose expression correlates with the survival of tumors, identifying new biomarkers and potential targets for therapeutics cell.com/cell/fulltext/… #NBThighlight

Wen-Wei Liang (@wenweiliang) 's Twitter Profile Photo

Big thanks to Neville for the insightful tutorial on our work! Grateful for the guidance and support every step of the way.

Wen-Wei Liang (@wenweiliang) 's Twitter Profile Photo

Excited to share our recent Cell publication in #cshldata24 #biodata24! Drop by #123 at Busch to know more about identification of essential lncRNAs using new kind of CRISPR screen!

Excited to share our recent Cell publication in #cshldata24 #biodata24! Drop by #123 at Busch to know more about identification of essential lncRNAs using new kind of CRISPR screen!
Yu-Jung Chen (@yujungche) 's Twitter Profile Photo

I’m excited to share our latest study in @nature on this novel compound called Gliocidin, that targets glioblastoma (#GBM), the most malignant brain tumor. #drugdiscovery #cancer #cancermetabolism GSK Graduate School Memorial Sloan Kettering Cancer Center nature.com/articles/s4158…

Wen-Wei Liang (@wenweiliang) 's Twitter Profile Photo

Every time I hear about this story, I’m amazed by how their CRISPR-Cas9 screen uncovers the missing jigsaw piece in the mechanism of this glioblastoma drug—and by my friend and fellow climber Yu-Jung Chen brilliance in connecting the dots. Now it’s finally out in nature!

NY Genome Center (@nygenome) 's Twitter Profile Photo

NIH's new policy (NOT-OD-25-068) capping indirect cost reimbursement at 15% threatens the future of research, training, & scientific infrastructure at research institutions nationwide. The NYGC has drafted a petition urging reversal. Please sign & share: bit.ly/40KK21a